Concepedia

Xixi Cheng

XC

Statistics

Publications

12

Citations

880

H-Index

11

Active since

2014

Affiliations

Tianjin Medical University(Current)

Chinese Academy of Sciences

Westmead Institute

Shanxi Normal University

The University of Sydney

Xixi Cheng is an author at Tianjin Medical University specializing in inflammation, hepatic inflammatory injury, and inflammatory liver injury.

Publications per year

2014–2024

12

Publications

12

tRF/miR-1280 Suppresses Stem Cell–like Cells and Metastasis in Colorectal Cancer

Bingqing Huang, Huipeng Yang, Xixi Cheng et al. · Cancer Research · 2017 · 341 citations

Medicine, Molecular Biology, Oncology +17

Mesenchymal stem cells and their secreted molecules predominantly ameliorate fulminant hepatic failure and chronic liver fibrosis in mice respectively

Biao Huang, Xixi Cheng, Huafeng Wang et al. · Journal of Translational Medicine · 2016 · 187 citations · Full text

Medicine, Cell Biology, Pathology +15

Adiponectin promotes pancreatic cancer progression by inhibiting apoptosis via the activation of <i>AMPK/Sirt1/PGC-1α</i> signaling

Bingqing Huang, Xixi Cheng, Dan Wang et al. · Oncotarget · 2014 · 87 citations · Full text

Life Sciences, Cancer Biology, Oncology +17

Adiponectin-derived active peptide ADP355 exerts anti-inflammatory and anti-fibrotic activities in thioacetamide-induced liver injury

Huafeng Wang, Huan Zhang, Zimu Zhang et al. · Scientific Reports · 2016 · 63 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

Embelin inhibits pancreatic cancer progression by directly inducing cancer cell apoptosis and indirectly restricting IL-6 associated inflammatory and immune suppressive cells11These authors contributed equally to this work.

Meiyu Peng, Bingqing Huang, Qi Zhang et al. · Cancer Letters · 2014 · 56 citations

Life Sciences, Cancer Biology, Oncology +15

1–5 of 12